First-ever clinical data supporting safety and efficacy of in vivo CAR-T Therapy in refractory systemic lupus erythematosus (SLE) patients. Data shows low dose of HN2301 reprogrammed up to 60% of CD8 ...

BLACKSBURG, Va.--(BUSINESS WIRE)--NImmune Biopharma, (“NImmune”), a private late-clinical-stage precision immunology biopharmaceutical company focused on the discovery and development of best-in-class ...

A growing body of research now suggests that the next wave of progress may not come from a new “miracle drug,” but from a more integrated approach: combining topical therapies with systemic ...

Adjuvant Chemotherapy in Premenopausal Patients With Hormone-Positive Breast Cancer With a Recurrence Score of 16-25: A Retrospective Analysis Using the National Cancer Database Patients who underwent ...